DC21706 |
STX3451 |
A non-steroidal sulphamate analogue of 2-methoxyoestradiol (2ME2) and microtubule disruptor, shows anti-proliferative activity against NCI 60 cell lines with mean GI50 of 50 nM. |
|
DC11919 |
Arimoclomol
Featured
|
A nontoxic heat shock protein (HSP) coinducer and potentiator of the heat shock response. |
|
DC11920 |
Arimoclomol maleate
Featured
|
A nontoxic, orally active heat shock protein (HSP) coinducer and potentiator of the heat shock response. |
|
DC24034 |
Coluracetam |
A nootropic agent that enhances high-affinity choline uptake. |
|
DC21342 |
MPT0L145 |
A nove potent, dual FGFR and PIK3C3 inhibitor with Kd of 0.53 nM for PIK3C3. |
|
DC20550 |
SHP2 inhibitor 2 |
A nove potent, selective and reversible SHP2 inhibitor with Ki of 0.51 uM. |
|
DC11523 |
Landipirdine |
A novel 5-HT receptor antagonist for the treatment of Parkinson's disease.. |
|
DC11793 |
UMB-32 |
A novel a potent, selective inhibitor of BRD4 with Kd of 550 nM, cellular IC50 of 724 nM. |
|
DC23493 |
Ladarixin |
A novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM. |
|
DC23467 |
Ladarixin sodium |
A novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM. |
|
DC20706 |
AVN-211 |
A novel and highly selective 5-HT6 receptor small molecule antagonist with Ki of 2.34 nM. |
|
DC22565 |
K-Ras G12C-IN-3 |
A novel and irreversible inhibitor of mutant K-ras G12C.. |
|
DC22572 |
K-Ras G12C-IN-2 |
A novel and irreversible inhibitor of mutant K-ras G12C.. |
|
DC22573 |
K-Ras G12C-IN-1 |
A novel and irreversible inhibitor of mutant K-ras G12C.. |
|
DC22587 |
FT011
Featured
|
FT011 is an anti-fibrotic agent, reduces mRNA expression of collagens I and III and inhibits collagen synthesis. |
|
DC11888 |
Arfolitixorin |
A novel antifolate modulator compound.. |
|
DC22391 |
Olorofim(F-901318) |
Olorofim (F901318) selectively inhibits fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the pyrimidine biosynthesis pathway. Olorofim (F901318). Olorofim exhibits excellent activity against A. fumigatus and other Aspergillus spp. |
|
DC11998 |
IND-114338 |
A novel antiprion compound with EC50 of 68 nM, significantly increases monoglycosylated/diglycosylated PrPSc.. |
|
DC11534 |
Sudoterb
Featured
|
A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.. |
|
DC11535 |
Sudoterb dihydrchloride |
A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.. |
|
DC11663 |
GS-5759 |
A novel bifunctional PDE4 inhibitor (IC50=5 nM) and long acting β2-adrenoceptor agonist (EC50=8 nM). |
|
DC11997 |
IND125 |
A novel brain penetrant antiprion compound with EC50 of 57 nM, prevents both PrP(Sc) accumulation and astrocytic gliosis in the cerebrum. |
|
DC11792 |
UMB-136 |
A novel bromodomain BRD4 inhibitor that significantly induces HIV-1 reactivation. |
|
DC22507 |
SCH-00013 |
A novel cardiotonic agent that acts as a calcium sensitizer with no chronotropic activity in mammalian cardiac muscle, elicits positive inotropic effect in dog and rabbit ventricular muscles (EC50=9.2 uM). |
|
DC11785 |
IHR-1 |
A novel cell membrane impermeable smoothened antagonist with IC50 of 7.6 nM in Hh-dependent Gli transcriptional activity assay. |
|
DC11784 |
IHR-Nac |
A novel cell permeable smoothened antagonist with IC50 of 3.1 nM in Hh-dependent Gli transcriptional activity assay. |
|
DC22789 |
5S rRNA modificator 2 |
A novel chemical probe that enable selective 2’-hydroxyl acylation for accurate RNA structural analysis in living cells.. |
|
DC11628 |
HIV-1 Integrase Inhibitor 1 |
A novel compound that disrupts the HIV-1 integrase LEDGF interaction. |
|
DC11521 |
Dotinurad
Featured
|
Dotinurad is a novel compound that exhibits a remarkable uric acid excretion-promoting action. |
|
DC20796 |
BIOD303 |
A novel conformational modulator of α-synuclein with EC50 of 105 uM, potentially outcompetes spermine in binding to α-synuclein. |
|